Steering Committee
The 13 members of the OxCD3 Steering Committee, listed below, are responsible for managing funding flexibility and reviewing funding allocation to Work Packages in light of recent clinical and industrial developments and the recommendations of the IAB.
Dr Pavel Novak
Industrial member
Storz
Industrial member
Storz
Dr Richard Green
Industrial member
Pfizer
Industrial member
Pfizer
Dr Matthew Weaver
EPSRC Representative
EPSRC Representative
Dr Marianne Ashford
Industrial member
AstraZeneca
Industrial member
AstraZeneca
Dr Christopher van der Walle
Industry member
MedImmune
Industry member
MedImmune
© OXCD3 2016